Topic · page 23 of 25

Pediatric rheumatology

Juvenile idiopathic arthritis (systemic juvenile idiopathic arthritis included), childhood-onset lupus, juvenile dermatomyositis, pediatric vasculitis (Kawasaki disease, IgA vasculitis in children), pediatric autoinflammatory disease, transition from pediatric to adult care

Briefs 881–920 of 974 placed here, newest publication first

Briefs in Pediatric rheumatology

Newest publication first

Arthritis Res Ther8 Feb 2023
Identification of candidate genes and pathways associated with juvenile idiopathic arthritis by integrative transcriptome-wide association studies and mRNA expression profiles
Research article
Pediatr Rheumatol Online J7 Feb 2023
Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates
Cohort study
Pediatr Rheumatol Online J6 Feb 2023
Axial involvement in enthesitis-related arthritis: results from a single-center cohort
Cohort study
Joint Bone Spine6 Feb 2023
Validity of ultrasonography in detecting enthesitis in children: A systematic literature review
Meta-analysis
Clin Exp Rheumatol3 Feb 2023
Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: the TURSIS study
Cohort study
J Rheumatol1 Feb 2023
Do Patterns of Early Disease Severity Predict Grade 12 Academic Achievement in Youths With Childhood-Onset Chronic Rheumatic Diseases?
Cohort study
Rheumatology (Oxford)30 Jan 2023
The incidence of Kawasaki disease using hospital admissions data for England 2006–2021
Cohort study
Arthritis Care Res (Hoboken)29 Jan 2023
Patient‐Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two‐Year Results From an International Phase III Study
Secondary analysis
Pediatr Rheumatol Online J27 Jan 2023
Childhood-onset primary Sjögren’s syndrome in a tertiary center in China: clinical features and outcome
Cohort study
Pediatr Rheumatol Online J25 Jan 2023
Macrophage activation syndrome in children with Kikuchi-Fujimoto disease
Cohort study
Rheumatology (Oxford)25 Jan 2023
Anti-SARS-CoV-2 vaccination in adolescent and adult patients with juvenile-onset systemic lupus erythematosus: tolerability and impact on disease activity
Cohort study
Pediatr Rheumatol Online J25 Jan 2023
Pain-coping scale for children and their parents: a cross-sectional study in children with musculoskeletal pain
Cross-sectional study
Rheumatology (Oxford)25 Jan 2023
Predictors of long-term functional outcomes of juvenile idiopathic arthritis–enthesitis-related arthritis: a single centre experience
Cross-sectional study
Pediatr Rheumatol Online J23 Jan 2023
Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis
Cohort study
Arthritis Rheumatol23 Jan 2023
The Characteristics of Patients With COVID‐19–Associated Pediatric Vasculitis: An International, Multicenter Study
Cohort study
Pediatr Rheumatol Online J21 Jan 2023
An iceberg I can’t handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya
Research article
Rheumatology (Oxford)20 Jan 2023
COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases
Cohort study
Rheumatology (Oxford)20 Jan 2023
Urine proteomics by mass spectrometry identifies proteins involved in key pathogenic pathways in patients with juvenile dermatomyositis
Cross-sectional study
Semin Arthritis Rheum18 Jan 2023
Developing electronic health record algorithms that accurately identify patients with juvenile idiopathic arthritis
Diagnostic or prognostic study
Pediatr Rheumatol Online J18 Jan 2023
Multi-inflammatory syndrome in children (MIS-C) associated with COVID-19: a nursing perspective experience report from a high-income tertiary paediatric hospital context
Research article
Arthritis Care Res (Hoboken)18 Jan 2023
Data‐Driven Magnetic Resonance Imaging Definitions for Active and Structural Sacroiliac Joint Lesions in Juvenile Spondyloarthritis Typical of Axial Disease: A Cross‐Sectional International Study
Cross-sectional study
Arthritis Care Res (Hoboken)18 Jan 2023
Probability of Response in the First Sixteen Weeks After Starting Biologics: An Analysis of Juvenile Idiopathic Arthritis Biologics Trials
Secondary analysis
Ann Rheum Dis10 Jan 2023
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force
Guideline or statement
Rheumatology (Oxford)10 Jan 2023
Epigenetic changes in inflammatory arthritis monocytes contribute to disease and can be targeted by JAK inhibition
Mechanistic study
Arthritis Care Res (Hoboken)10 Jan 2023
New and Updated Recommendations for the Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis and Idiopathic Chronic Anterior Uveitis
Guideline or statement
Pediatr Rheumatol Online J9 Jan 2023
Effect of interleukin-1 antagonist on growth of children with colchicine resistant or intolerant FMF
Cohort study
Pediatr Rheumatol Online J6 Jan 2023
Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance
Cross-sectional study
Clin Exp Rheumatol5 Jan 2023
Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections
Cohort study
Pediatr Rheumatol Online J4 Jan 2023
Colchicine treatment can be discontinued in a selected group of pediatric FMF patients
Cohort study
Rheumatology (Oxford)30 Dec 2022
Risk factors for haemodynamic compromise in multisystem inflammatory syndrome in children: a multicentre retrospective study
Cohort study
Semin Arthritis Rheum24 Dec 2022
Synovial fibroblasts in juvenile idiopathic arthritis: A scoping review
Research article
Ann Rheum Dis23 Dec 2022
Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis
Mechanistic study
Arthritis Care Res (Hoboken)23 Dec 2022
Multicenter Study of Utility and Acceptability of Depression and Anxiety Screening in Adolescents and Young Adults With Childhood‐Onset Systemic Lupus
Cross-sectional study
Arthritis Care Res (Hoboken)21 Dec 2022
Disease Recapture Rates After Medication Discontinuation and Flare in Juvenile Idiopathic Arthritis: An Observational Study Within the Childhood Arthritis and Rheumatology Research Alliance Registry
Cohort study
J Rheumatol15 Dec 2022
Insurance Status and Tumor Necrosis Factor Inhibitor Initiation Among Children With Juvenile Idiopathic Arthritis in the CARRA Registry
Cohort study
J Rheumatol15 Dec 2022
High Rates of Symptoms of Major Depressive Disorder and Panic Disorder in a Canadian Sample of Adolescents With Juvenile Idiopathic Arthritis
Cross-sectional study
Rheumatology (Oxford)14 Dec 2022
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort
Cohort study
Rheumatology (Oxford)14 Dec 2022
Patients’ and parents’ satisfaction to improve patient care in JIA: factors determining acceptable symptom state measured with JAMAR
Cross-sectional study
Arthritis Rheumatol13 Dec 2022
Development and External Validation of a Model Predicting New‐Onset Chronic Uveitis at Different Disease Durations in Juvenile Idiopathic Arthritis
Diagnostic or prognostic study
Rheumatology (Oxford)10 Dec 2022
Infantile Takayasu: clinical features and long-term outcome
Cohort study

All 974 Briefs in ExploreShowing Briefs 881–920 of 974, newest first